Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence

Abstract Background Mesenchymal stem cells (MSCs) have been proposed to treat osteoarthritis (OA) for many years. However, clinical outcomes have been inconsistent due to biological variation between patients, differences in tissue source and preparation of the MSCs, and type of donor (e.g. allogeni...

Full description

Saved in:
Bibliographic Details
Main Authors: Houyi Sun, Haoxin Zhai, Kaifei Han, Heran Ma, Yi Tan, Shihao Li, Zhicheng Liu, Lei Cheng, Qunshan Lu, Libo Zhou, Peilai Liu
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Translational Medicine
Online Access:https://doi.org/10.1186/s12967-024-05814-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162726115999744
author Houyi Sun
Haoxin Zhai
Kaifei Han
Heran Ma
Yi Tan
Shihao Li
Zhicheng Liu
Lei Cheng
Qunshan Lu
Libo Zhou
Peilai Liu
author_facet Houyi Sun
Haoxin Zhai
Kaifei Han
Heran Ma
Yi Tan
Shihao Li
Zhicheng Liu
Lei Cheng
Qunshan Lu
Libo Zhou
Peilai Liu
author_sort Houyi Sun
collection DOAJ
description Abstract Background Mesenchymal stem cells (MSCs) have been proposed to treat osteoarthritis (OA) for many years. However, clinical outcomes have been inconsistent due to biological variation between patients, differences in tissue source and preparation of the MSCs, and type of donor (e.g. allogenic versus autologous). Here, we test the hypothesis that inconsistent clinical outcomes are related to variations in the stemness and senescence of the injected autologous adipose-derived (AD) MSCs. Methods In the prospective randomized trial, 45 knee OA patients were divided into two groups: Group 1 (n = 22) patients treated with high tibial osteotomy (HTO) alone and Group 2 (n = 23) patients treated with HTO followed by intra-articular injection of autologous AD-MSCs (HTO + AD-MSCs). MRI and X-ray were performed pre-operation and 12 months post-operation. WOMAC and VAS score were collected four times, every 6 months over a 24-month follow-up. We observed the proliferation and stemness of AD-MSCs selected from the 5 patients showing the most improvement and from the 5 patients with the least improvement, and completed further in vitro experiments including beta-galactosidase activity, reactive oxygen species and bioinformatic analysis. Results The results showed that patients treated with HTO + AD-MSCs had a significant reduction in knee OA severity as compared to patients treated with HTO alone. Moreover, we discovered that proliferation and colony forming efficiency of AD-MSCs selected from the 5 patients showing the most improvement performed significantly better than cells selected from the 5 patients with the least improvement. AD-MSCs from the patients with the most improvement also had lower amounts of senescent cells and intracellular reactive oxygen species. Conclusions Clinical outcomes of autologous AD-MSCs therapy in knee osteoarthritis are correlated with stem cell stemness and senescence. Our study highlights emerging opportunities and trends in precision medicine that could potentially improve autologous MSC-based therapies.
format Article
id doaj-art-b839b0fcbe2447b4ab21b0bb46e30b54
institution OA Journals
issn 1479-5876
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-b839b0fcbe2447b4ab21b0bb46e30b542025-08-20T02:22:29ZengBMCJournal of Translational Medicine1479-58762024-11-0122111810.1186/s12967-024-05814-3Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescenceHouyi Sun0Haoxin Zhai1Kaifei Han2Heran Ma3Yi Tan4Shihao Li5Zhicheng Liu6Lei Cheng7Qunshan Lu8Libo Zhou9Peilai Liu10Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityQilu Cell Therapy Technology Co., LtdQilu Cell Therapy Technology Co., LtdDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityKey Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong UniversityDepartment of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityAbstract Background Mesenchymal stem cells (MSCs) have been proposed to treat osteoarthritis (OA) for many years. However, clinical outcomes have been inconsistent due to biological variation between patients, differences in tissue source and preparation of the MSCs, and type of donor (e.g. allogenic versus autologous). Here, we test the hypothesis that inconsistent clinical outcomes are related to variations in the stemness and senescence of the injected autologous adipose-derived (AD) MSCs. Methods In the prospective randomized trial, 45 knee OA patients were divided into two groups: Group 1 (n = 22) patients treated with high tibial osteotomy (HTO) alone and Group 2 (n = 23) patients treated with HTO followed by intra-articular injection of autologous AD-MSCs (HTO + AD-MSCs). MRI and X-ray were performed pre-operation and 12 months post-operation. WOMAC and VAS score were collected four times, every 6 months over a 24-month follow-up. We observed the proliferation and stemness of AD-MSCs selected from the 5 patients showing the most improvement and from the 5 patients with the least improvement, and completed further in vitro experiments including beta-galactosidase activity, reactive oxygen species and bioinformatic analysis. Results The results showed that patients treated with HTO + AD-MSCs had a significant reduction in knee OA severity as compared to patients treated with HTO alone. Moreover, we discovered that proliferation and colony forming efficiency of AD-MSCs selected from the 5 patients showing the most improvement performed significantly better than cells selected from the 5 patients with the least improvement. AD-MSCs from the patients with the most improvement also had lower amounts of senescent cells and intracellular reactive oxygen species. Conclusions Clinical outcomes of autologous AD-MSCs therapy in knee osteoarthritis are correlated with stem cell stemness and senescence. Our study highlights emerging opportunities and trends in precision medicine that could potentially improve autologous MSC-based therapies.https://doi.org/10.1186/s12967-024-05814-3
spellingShingle Houyi Sun
Haoxin Zhai
Kaifei Han
Heran Ma
Yi Tan
Shihao Li
Zhicheng Liu
Lei Cheng
Qunshan Lu
Libo Zhou
Peilai Liu
Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
Journal of Translational Medicine
title Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
title_full Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
title_fullStr Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
title_full_unstemmed Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
title_short Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
title_sort clinical outcomes of autologous adipose derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence
url https://doi.org/10.1186/s12967-024-05814-3
work_keys_str_mv AT houyisun clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT haoxinzhai clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT kaifeihan clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT heranma clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT yitan clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT shihaoli clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT zhichengliu clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT leicheng clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT qunshanlu clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT libozhou clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence
AT peilailiu clinicaloutcomesofautologousadiposederivedmesenchymalstemcellcombinedwithhightibialosteotomyforkneeosteoarthritisarecorrelatedwithstemcellstemnessandsenescence